Immunogenicity and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine Among Infants, Toddlers, and Children in Western Burkina Faso: Results From a Clinical Trial of Alternative Immunization Schedules

Journal of the Pediatric Infectious Diseases Society (JPIDS)
Volume 8, Issue 5, November 2019
https://academic.oup.com/jpids/issue

 

ORIGINAL ARTICLES
Immunogenicity and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine Among Infants, Toddlers, and Children in Western Burkina Faso: Results From a Clinical Trial of Alternative Immunization Schedules
Jennifer C Moïsi, Seydou Yaro, Sita S Kroman, Clarisse Gouem, Dramane Bayane
J Pediatric Infect Dis Soc, Volume 8, Issue 5, November 2019, Pages 422–432, https://doi.org/10.1093/jpids/piy075
PCV13 has a satisfactory reactogenicity and immunogenicity profile when administered to infants, toddlers, and children according to alternative immunization schedules in Burkina Faso.